Pomerantz LLP Investigates Humana Inc. Securities Claims

Strategic Insights -

Pomerantz LLP, a leading corporate, securities, and antitrust class litigation firm, is investigating claims on behalf of investors of Humana Inc. over alleged securities fraud and unlawful business practices. The investigation follows a False Claims Act complaint filed by the U.S. Department of Justice against Humana and several other health insurance companies, alleging illegal kickbacks to insurance brokers in exchange for Medicare Advantage plan enrollments. Humana's stock price plummeted $6.20 per share, or 2.36%, to close at $256.04 per share on May 1, 2025, after the news of the DOJ's lawsuit.

Key Takeaways:

  • Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. regarding alleged securities fraud and unlawful business practices.
  • The investigation concerns a False Claims Act complaint filed by the U.S. Department of Justice against Humana and several other health insurance companies.
  • The complaint alleges that Humana paid hundreds of millions of dollars in illegal kickbacks to insurance brokers in exchange for Medicare Advantage plan enrollments.
  • Humana's stock price fell $6.20 per share, or 2.36%, to close at $256.04 per share on May 1, 2025, after the news of the DOJ's lawsuit.
  • Pomerantz LLP has a long history of recovering multimillion-dollar damages awards on behalf of class members and is recognized as one of the premier firms in corporate, securities, and antitrust class litigation.

Statistics:

  • $6.20: The amount by which Humana's stock price fell per share after the news of the DOJ's lawsuit.
  • 2.36%: The percentage decline in Humana's stock price on May 1, 2025.
  • 256.04: The closing price of Humana's stock share on May 1, 2025.
  • 2016: The year in which the alleged illegal kickbacks began.
  • 2021: The year in which the alleged illegal kickbacks allegedly ended.
  • 85: The number of years that Pomerantz LLP has been in the tradition of fighting for the rights of the victims of securities fraud and corporate misconduct.

Sources:

  • Pomerantz LLP
  • U.S. Department of Justice (source of the False Claims Act complaint)
  • Business Insider (source of Humana's stock price decline)